CDMO
Price
$12.44
Change
+$0.05 (+0.40%)
Updated
Jan 21, 03:54 PM (EDT)
Capitalization
792.51M
55 days until earnings call
RXRX
Price
$6.89
Change
+$0.36 (+5.51%)
Updated
Jan 21, 04:16 PM (EDT)
Capitalization
2.55B
42 days until earnings call
Ad is loading...

CDMO vs RXRX

Header iconCDMO vs RXRX Comparison
Open Charts CDMO vs RXRXBanner chart's image
Avid Bioservices
Price$12.44
Change+$0.05 (+0.40%)
Volume$100
Capitalization792.51M
Recursion Pharmaceuticals
Price$6.89
Change+$0.36 (+5.51%)
Volume$1.92K
Capitalization2.55B
CDMO vs RXRX Comparison Chart
Loading...
CDMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDMO vs. RXRX commentary
Jan 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDMO is a Hold and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 21, 2025
Stock price -- (CDMO: $12.39 vs. RXRX: $6.53)
Brand notoriety: CDMO and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDMO: 105% vs. RXRX: 66%
Market capitalization -- CDMO: $792.51M vs. RXRX: $2.55B
CDMO [@Biotechnology] is valued at $792.51M. RXRX’s [@Biotechnology] market capitalization is $2.55B. The market cap for tickers in the [@Biotechnology] industry ranges from $351.74B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDMO’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • CDMO’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, CDMO is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDMO’s TA Score shows that 2 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • CDMO’s TA Score: 2 bullish, 2 bearish.
  • RXRX’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than CDMO.

Price Growth

CDMO (@Biotechnology) experienced а -0.16% price change this week, while RXRX (@Biotechnology) price change was -5.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.37%. For the same industry, the average monthly price growth was +2.13%, and the average quarterly price growth was -0.58%.

Reported Earning Dates

CDMO is expected to report earnings on Mar 17, 2025.

RXRX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+1.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.55B) has a higher market cap than CDMO($793M). CDMO YTD gains are higher at: 0.324 vs. RXRX (-3.402). CDMO has higher annual earnings (EBITDA): -14.34M vs. RXRX (-350.86M). RXRX has more cash in the bank: 428M vs. CDMO (33.4M). RXRX has less debt than CDMO: RXRX (90.6M) vs CDMO (206M). CDMO has higher revenues than RXRX: CDMO (150M) vs RXRX (64.6M).
CDMORXRXCDMO / RXRX
Capitalization793M2.55B31%
EBITDA-14.34M-350.86M4%
Gain YTD0.324-3.402-10%
P/E RatioN/AN/A-
Revenue150M64.6M232%
Total Cash33.4M428M8%
Total Debt206M90.6M227%
FUNDAMENTALS RATINGS
CDMO: Fundamental Ratings
CDMO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDMORXRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 14 days ago
88%
Bearish Trend 14 days ago
90%
Momentum
ODDS (%)
Bullish Trend 14 days ago
82%
Bullish Trend 14 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 14 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 14 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 14 days ago
81%
Bullish Trend 14 days ago
84%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
Bearish Trend 29 days ago
80%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
CDMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCAJX12.560.11
+0.88%
Fidelity Advisor Climate Action A
HOOSX31.450.26
+0.83%
Hartford Schroders US Small Cap Opps R4
BIGRX37.650.19
+0.51%
American Century Discplnd Cor Val Inv
BIICX10.180.02
+0.20%
BlackRock Multi-Asset Income Instl
NBRIX14.020.01
+0.07%
Neuberger Berman Real Estate I

CDMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDMO has been loosely correlated with AXON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CDMO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDMO
1D Price
Change %
CDMO100%
+0.08%
AXON - CDMO
49%
Loosely correlated
+1.37%
DRMA - CDMO
42%
Loosely correlated
N/A
ARRY - CDMO
41%
Loosely correlated
-0.14%
VCYT - CDMO
38%
Loosely correlated
-1.27%
MGTX - CDMO
35%
Loosely correlated
+5.56%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with CRSP. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+2.03%
CRSP - RXRX
64%
Loosely correlated
+0.57%
BEAM - RXRX
59%
Loosely correlated
+0.17%
PRME - RXRX
55%
Loosely correlated
+0.70%
NTLA - RXRX
53%
Loosely correlated
+0.85%
GLUE - RXRX
50%
Loosely correlated
-1.82%
More